Myeloid Malignancies
Rare Disease·MeSH: Myelodysplastic Syndromes
5 drugs in development·5 companies·3 clinical trials
Drug Pipeline by Phase
Approved(4)
Phase 1(1)
| Drug | Company |
|---|---|
| KT-253 | Kymera Therapeutics, Inc. (KYMR) |
Compare drugs
Frequently asked questions
How many drugs are in development for Myeloid Malignancies?
BioSniper tracks 5 drugs in development for Myeloid Malignancies across 5 companies.
How many clinical trials target Myeloid Malignancies?
There are 3 clinical trials targeting Myeloid Malignancies tracked by BioSniper.
Deep-dive into Myeloid Malignancies
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis